What are the diagnostic criteria and treatment for euglycemic diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Euglycemic Diabetic Ketoacidosis

Euglycemic DKA is diagnosed when blood glucose is <250 mg/dL (some sources use <200 mg/dL) in the presence of metabolic acidosis (pH <7.3, bicarbonate <18 mEq/L), elevated anion gap (>10-12 mEq/L), and positive serum or urine ketones. 1, 2, 3, 4

Core Diagnostic Criteria

The diagnosis requires all of the following laboratory findings:

  • Blood glucose <250 mg/dL (or <200 mg/dL by some definitions) - this is the key distinguishing feature from typical DKA 1, 3, 4, 5
  • Arterial pH <7.3 (venous pH typically 0.03 units lower is acceptable) 1, 2
  • Serum bicarbonate <18 mEq/L 1, 2
  • Anion gap >10-12 mEq/L (calculated as Na+ minus [Cl- + HCO3-]) 1, 2
  • Positive ketones in blood or urine 1, 2, 3

Essential Laboratory Workup

Obtain the following tests immediately upon suspicion:

  • Plasma glucose 6, 2
  • Arterial or venous blood gas for pH assessment 6, 2
  • Complete metabolic panel including electrolytes, BUN, creatinine 6, 2
  • Serum ketones (β-hydroxybutyrate is preferred over nitroprusside method) 1, 2
  • Calculated anion gap and serum osmolality 6, 2
  • Urinalysis for ketones 6, 2
  • Complete blood count with differential 1, 2
  • Electrocardiogram 6, 2

Critical Diagnostic Pitfall

The normal or near-normal glucose level masks the underlying ketoacidosis, leading to delayed diagnosis and treatment. 3, 4, 5 You must check blood pH and ketones in any ill diabetic patient regardless of glucose levels, especially if they present with nausea, vomiting, malaise, or fatigue. 3, 5

Preferred Ketone Measurement

Direct measurement of β-hydroxybutyrate in blood is the preferred method for monitoring DKA. 2 The nitroprusside method only measures acetoacetic acid and acetone, not β-hydroxybutyrate (the predominant ketone in DKA), and can be misleading during treatment as β-hydroxybutyrate converts to acetoacetic acid. 1, 2

Common Etiologies to Identify

When euglycemic DKA is diagnosed, immediately investigate these precipitating factors:

  • SGLT2 inhibitor use (canagliflozin, dapagliflozin, empagliflozin) - the most important modern cause 1, 6, 2, 4, 7, 5
  • Starvation or severe carbohydrate restriction (including ketogenic diets) 8, 4, 5
  • Recent insulin use that lowered glucose but didn't prevent ketosis 3, 4
  • Pregnancy 4, 5
  • Heavy alcohol consumption 4, 5
  • Chronic liver disease 4, 5
  • Infection (urinary tract infection, sepsis) 3, 5
  • Insulin pump failure 3
  • Nausea/vomiting leading to decreased oral intake 3, 5

Differential Diagnosis to Exclude

Rule out other causes of high anion gap metabolic acidosis:

  • Lactic acidosis (measure blood lactate) 1
  • Salicylate toxicity (measure serum salicylate) 1
  • Methanol or ethylene glycol ingestion (check osmolar gap, look for calcium oxalate crystals in urine for ethylene glycol) 1
  • Chronic renal failure (typically causes hyperchloremic acidosis) 1

Monitoring Parameters

Once diagnosed, draw blood every 2-4 hours for:

  • Serum electrolytes 1, 6, 2
  • Glucose 1, 6, 2
  • BUN and creatinine 1, 6, 2
  • Osmolality 1, 6, 2
  • Venous pH 1, 6, 2
  • Blood glucose every 1-2 hours initially 6, 2

Continuous cardiac monitoring is necessary due to electrolyte shifts and arrhythmia risk. 6

Resolution Criteria

Euglycemic DKA is resolved when ALL of the following are achieved:

  • Glucose <200 mg/dL 1, 6, 2
  • Serum bicarbonate ≥18 mEq/L 6, 2
  • Venous pH >7.3 6, 2
  • Anion gap ≤12 mEq/L 6, 2

Key Clinical Pearl

In patients taking SGLT2 inhibitors, discontinue the medication 3-4 days before any planned surgery to prevent euglycemic DKA. 1, 6, 2 SGLT2 inhibitors cause increased urinary glucose excretion, maintaining lower glucose levels while ketoacidosis develops unchecked. 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma.

Endocrinology, diabetes & metabolism case reports, 2017

Research

Euglycemic Diabetic Ketoacidosis: A Review.

Current diabetes reviews, 2017

Research

Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.

The American journal of emergency medicine, 2021

Guideline

Management of Diabetic Ketoacidosis with Concurrent Hypertriglyceridemia-Induced Pancreatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.